Triad Wealth Partners’s Organon & Co OGN Stock Holding History

Triad Wealth Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14	Closed	-$290	–	626
2024 Q2	$290	Buy	+14	New	+$278	﹤0.01%	932

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.66B AUM 23.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Triad Wealth Partners's OGN Position: Q3 2024 in Review

Triad Wealth Partners sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 14 shares — an estimated $290 sold.

Triad Wealth Partners first reported a position in OGN in Q2 2024 and held it in 1 quarter. The position peaked at $290 in Q2 2024. 725 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

Triad Wealth Partners reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
Triad Wealth Partners sold 14 Organon & Co shares in Q3 2024, an estimated $290.
Triad Wealth Partners first reported a position in Organon & Co in Q2 2024 and held it in 1 quarter.
Triad Wealth Partners's Organon & Co position peaked at $290 in Q2 2024.
725 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Triad Wealth Partners's 13F filing for Q3 2024, filed 21 Oct 2024.